Editor's Choice
Obviously
BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7572.0-f (Published 12 October 2006) Cite this as: BMJ 2006;333:0-fRelated articles
- Analysis And Comment Published: 28 September 2006; BMJ 333 doi:10.1136/bmj.333.7570.701
- Research Published: 12 October 2006; BMJ 333 doi:10.1136/bmj.38950.561400.55
- Editorial Published: 12 October 2006; BMJ 333 doi:10.1136/bmj.38996.499410.BE
- Editorial Published: 12 October 2006; BMJ 333 doi:10.1136/bmj.38996.709340.BE
- Analysis And Comment Published: 12 October 2006; BMJ 333 doi:10.1136/bmj.38987.492014.94
- Letter Published: 12 October 2006; BMJ 333 doi:10.1136/bmj.333.7572.807-b
- Letter Published: 12 October 2006; BMJ 333 doi:10.1136/bmj.333.7572.807
- Letter Published: 12 October 2006; BMJ 333 doi:10.1136/bmj.333.7572.807-a
- RESEARCH Published: 15 September 2006; BMJ doi:10.1136/bmj.38950.561400.55
See more
- Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysisBMJ December 05, 2016, 355 i6188; DOI: https://doi.org/10.1136/bmj.i6188
- NHS to fund large trial of pre-exposure prophylaxis for HIV preventionBMJ December 05, 2016, 355 i6537; DOI: https://doi.org/10.1136/bmj.i6537
- Bill to boost medical research funding and speed drug approval passes US houseBMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498
- Alpha blockers for treatment of ureteric stones: systematic review and meta-analysisBMJ December 01, 2016, 355 i6112; DOI: https://doi.org/10.1136/bmj.i6112
- Sixty seconds on . . . solanezumabBMJ November 29, 2016, 355 i6389; DOI: https://doi.org/10.1136/bmj.i6389